Subclinical Hypothyroidism and the Heart

Table of Contents
View All
Table of Contents

In hypothyroidism, the thyroid gland fails to produce enough of the thyroid hormone thyroxine (also called T4). Because T4 is critically important in regulating the body's metabolism, digestive function, muscle function, and cardiac function, hypothyroidism is always a serious problem.

The thyroid gland itself is regulated by the hormone TSH (thyroid stimulating hormone), which is produced in the pituitary gland. If the thyroid gland is not producing enough T4, the TSH levels increase in order to stimulate the thyroid to work harder. In hypothyroidism—in which the thyroid simply cannot make enough T4—the TSH levels are almost always greatly elevated.

subclinical thyroidism
Verywell / Emily Roberts

What Is Subclinical Hypothyroidism?

Subclinical hypothyroidism is the condition in which T4 levels remain in the normal range (that is, frank hypothyroidism is not present), but TSH levels are elevated: the high TSH levels are required in order to maintain that normal T4 level. So subclinical hypothyroidism implies that the thyroid gland itself is not functioning entirely normally. It's only by "whipping" the thyroid (with high TSH levels) that adequate T4 levels can be maintained.

There is quite a bit of controversy today regarding the true significance of subclinical hypothyroidism. Because the T4 levels are in fact normal in this condition, in theory, subclinical hypothyroidism should not be much of a problem. But evidence suggests that subclinical hypothyroidism does produce clinical problems at least sometimes—and so, at least in some cases, it should be treated.

Perhaps the biggest concern with subclinical hypothyroidism is that it may affect the heart if the TSH level goes above 10.


This condition is diagnosed with blood tests, specifically, by measuring T4 levels and TSH levels. Subclinical hypothyroidism is present if the T4 levels are in the normal range (4 to 12 ug/dL), and the TSH levels are above the normal range (0.3 to 4 mU/L). However, many experts consider subclinical hypothyroidism to be "significant" only when the TSH levels are substantially elevated: above 10 mU/L.

Should You Be Tested?

In the old days (a decade or two ago), thyroid function testing was a routine part of a medical evaluation. But in the interest of cost savings, it is often no longer routine.

It's reasonable to ask your healthcare provider to get thyroid blood tests if you have symptoms suggestive of hypothyroidism (see above), if you have elevated cholesterol levels, or if you just want to be sure you're doing everything you can to reduce your cardiac risk.


It is believed that subclinical hypothyroidism is merely a mild form, or an early form, of the disorders that commonly produce frank hypothyroidism—most typically autoimmune thyroiditis (Hashimoto's thyroiditis). Indeed, over time, as many as half the people with subclinical hypothyroidism will go on to develop frank hypothyroidism, with low T4 levels and all the symptoms that go along with it. So, one reason some healthcare providers treat subclinical hypothyroidism is to prevent the eventual development of the much more serious condition of true hypothyroidism.

Thyroid Disease Doctor Discussion Guide

Get our printable guide for your next doctor's appointment to help you ask the right questions.

Doctor Discussion Guide Woman


While this condition apparently doesn't produce symptoms in most people, some will admit to mild symptoms suggestive of hypothyroidism, such as constipation, fatigue, or unexplained weight gain. It's also been suggested that people with subclinical hypothyroidism may have a higher incidence of significant anxiety, depression, or cognitive disorders.

How It Affects the Heart

Aside from the risk of eventually developing frank hypothyroidism, the chief worry with subclinical hypothyroidism is that it is associated with an increased incidence of cardiovascular disease.

Several studies have now shown an association between high TSH levels (greater than 10 mU/L) and the development of coronary artery disease (CAD). In a pooled analysis of several clinical studies which included more than 25,000 patients, subclinical hypothyroidism was associated with an increased incidence of heart attack, symptomatic CAD, and cardiac death. Another pooled analysis found a significantly increased risk of heart failure in patients with subclinical hypothyroidism. And several studies have associated subclinical hypothyroidism with increased cholesterol levels.

While an association does not prove cause-and-effect, it is notable that overt hypothyroidism certainly does produce significant cardiac disease. This fact gives credence to the idea that subclinical hypothyroidism may also negatively impact the heart. The increase in cardiac risk seen with subclinical hypothyroidism is indeed the most worrisome feature of this condition.


Subclinical hypothyroidism can be treated by giving thyroid hormone replacement therapy. Treatment is guided by carefully monitoring TSH blood levels; sufficient thyroid hormone is given to reduce TSH levels back into the normal range.

There is only limited evidence from clinical studies that treating subclinical hypothyroidism improves symptoms. In studies that suggest that it does reduce symptoms, the measurable benefit appears limited to those patients whose initial TSH levels are substantially elevated (that is, greater than 10 mU/L).

Similarly, evidence that treating subclinical hypothyroidism reduces the risk of heart disease is also limited. In a study conducted in Great Britain, among younger patients (less than 70 years of age) with subclinical hypothyroidism, the risk of subsequent heart disease was significantly lower in patients who received thyroid hormone therapy. No treatment benefit was seen in older patients with subclinical hypothyroidism.

Further, treating subclinical hypothyroidism significantly improves several cardiovascular risk factors, including cholesterol levels, CRP levels, and vascular function.

The Bottom Line

Most experts recommend treating subclinical hypothyroidism when TSH levels are greater than 10 mU/L, whether or not symptoms are present. The exception to this is women who are pregnant or trying to become pregnant.

Whether subclinical hypothyroidism ought to be treated when TSH levels are less than 10 mU/L remains a point of contention. Many healthcare providers recommend treatment even in this lower range if patients have symptoms suggestive of hypothyroidism, or if they have elevated cholesterol levels or other risk factors for cardiac disease.

9 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Gosi SKY, Garla VV. Subclinical Hypothyroidism. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.

  2. Aversa T, Valenzise M, Corrias A, et al. Subclinical hyperthyroidism when presenting as initial manifestation of juvenile Hashimoto's thyroiditis: first report on its natural history. J Endocrinol Invest. 2014;37(3):303-8. doi:10.1007/s40618-014-0054-0

  3. Patil N, Rehman A, Jialal I. Hypothyroidism. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.

  4. Gencer B, Collet TH, Virgini V, et al. Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: An Individual Participant Data Analysis From 6 Prospective CohortsCirculation 2012; 126:1040. doi:10.1161/CIRCULATIONAHA.112.096024

  5. Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and MortalityJAMA 2010; 304:1365. doi:10.1001/jama.2010.1361

  6. Duntas LH, Chiovato L. Cardiovascular Risk in Patients with Subclinical Hypothyroidism. Eur Endocrinol. 2014;10(2):157-160. doi:10.17925/EE.2014.10.02.157

  7. Abreu IM, Lau E, De Sousa Pinto B, Carvalho D. Subclinical hypothyroidism: to treat or not to treat, that is the question! A systematic review with meta-analysis on lipid profile. Endocr Connect. 2017;6(3):188-199. doi:10.1530/EC-17-0028

  8. Razvi S, Weaver JU, Butler TJ, Pearce SH. Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and MortalityArch Intern Med 2012. doi:10.1001/archinternmed.2012.1159

  9. Stockigt J. Clinical Strategies in the Testing of Thyroid Function. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA):, Inc.

By Richard N. Fogoros, MD
Richard N. Fogoros, MD, is a retired professor of medicine and board-certified in internal medicine, clinical cardiology, and clinical electrophysiology.